Adverse Drug Reaction News Bulletins
ADR News Bulletin 2020 December (Volume 22 Number 3)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
1 December 2020
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Advisory on restriction on the use of montelukast and neuropsychiatric effects
Characteristics of sibutramine-induced adverse events due to adulterated health products
Reminder to verify HLA-B*1502 status in new patients of Asian ancestry before starting carbamazepine treatment
Voluntary withdrawal of Esmya™ (ulipristal acetate) Tablet 5mg in Singapore due to risk of serious liver injury
Risk of drug-induced liver injury associated with the use of pirfenidone
AE Case in Focus: Test Yourself
Reporting vaccine adverse events
Click on the link below to download the issue in PDF: